Literature DB >> 9915570

Major genetic effects on airway-parenchymal dysanapsis of the lung: the Humboldt family study.

Y Chen1, J A Dosman, D C Rennie, L A Lockinger.   

Abstract

We examined familial resemblance and performed segregation analysis for the maximal expiratory flow rate at 50% of vital capacity (Vmax50) and the ratio of Vmax50 to forced vital capacity (FVC), based on data from 309 nuclear families with 1,045 individuals in the town of Humboldt, Saskatchewan, in 1993. Vmax50 is considered as an index of airway function and Vmax50/FVC is considered as an index of airway-parenchymal dysanapsis. Both Vmax50 and Vmax50/FVC were preadjusted for host characteristics (age, height, and weight), environmental factors, and history of respiratory symptoms and diseases in four separate groups (mothers, fathers, daughters, and sons). Both Vmax50 and Vmax50/FVC showed low father-mother correlations and significant parent-offspring and sibling-sibling correlations. Segregation analysis indicated that for residual Vmax50, the model of no-parent-offspring transmission with possible heterogeneity between two generations fitted the data as well as did the general model with arbitrary transmission probabilities. The Mendelian hypothesis for Vmax50 was rejected, which was consistent with our previous findings for other indexes of airway function. For residual Vmax50/FVC, however, a single locus explained all the familial resemblance and both no-parent-offspring-transmission hypotheses [tau(AA) = tau(AB) = tau(BB) = qA and tau(AA) = tau(AB) = tau(BB)] were rejected. The study provides evidence for a single locus influencing airway-parenchymal dysanapsis.

Entities:  

Mesh:

Year:  1999        PMID: 9915570     DOI: 10.1002/(SICI)1098-2272(1999)16:1<95::AID-GEPI8>3.0.CO;2-6

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  3 in total

Review 1.  Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary function.

Authors:  Y Chen
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

Authors:  D L DeMeo; V J Carey; H A Chapman; J J Reilly; L C Ginns; F E Speizer; S T Weiss; E K Silverman
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

3.  Practical surrogate marker of pulmonary dysanapsis by simple spirometry: an observational case-control study in primary care.

Authors:  Satomi Shiota; Masako Ichikawa; Kazuhiro Suzuki; Yoshinosuke Fukuchi; Kazuhisa Takahashi
Journal:  BMC Fam Pract       Date:  2015-03-26       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.